The device consists of an implantable battery pack and thin wires that are inserted into blood vessels in the upper chest near the nerve that is responsible for sending signals to the diaphragm to fuel breathing. If the device detects the patient is not breathing, it will stimulate the nerve to move the diaphragm to initiate normal breathing.
The Remede System is not intended for use in patients who need MRI scans, have an active infection or are diagnosed with obstructive sleep apnea, a condition where the upper airway is partially or completely blocked.
More articles on supply chain:
FDA commissioner: High drug prices are a ‘public health concern the FDA should address’
Judge ruling allows drug ‘price gouging’ law to take effect in Maryland
Rite Aid names former Walgreens executive as president, COO
